Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been clinically diagnosed with type 2 diabetes
- People whose blood sugar control measure (called HbA1c) is above 7% but no higher than 12% at the start of the trial
- People whose treating doctor has decided to start them on a medication called semaglutide (available as a tablet or injection) as part of their usual care
Who may not be able to join:
- People who are pregnant or breastfeeding at the time of enrolment
- People who have had a severe allergic reaction or serious side effects to a class of diabetes medications known as GLP-1 receptor agonists in the past
- People for whom semaglutide is medically unsuitable according to the official product guidelines — for example, those with severe stomach or bowel disease, or certain types of hormone-related tumours (confirm with trial site)
- People with another serious health condition that, in the trial doctor's judgement, could affect their ability to participate or make the results harder to interpret
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: María Natalia Nachón, MD, Hospital General de Agudos Dr Enrique Tornú
Phone: 1520497361
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in glycated hemoglobin (HbA1c) levels from baseline to 3, 6, and 12 months of follow-up.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.